首页|仙鹤草-白术对腹泻型肠易激综合征脾虚湿阻证患者的疗效观察

仙鹤草-白术对腹泻型肠易激综合征脾虚湿阻证患者的疗效观察

扫码查看
目的 探讨仙鹤草-白术治疗腹泻型肠易激综合征脾虚湿阻证的临床效果及机制。方法 将120例患者随机分为治疗组和对照组,每组60例。治疗组予以仙鹤草-白术汤剂口服治疗,对照组予以培菲康联合蒙脱石散口服治疗,疗程1个月。观察治疗后2组主要症状改善情况、综合疗效以及治疗前后血清5-羟色胺(5-HT)、白细胞介素-1β(IL-1β)水平。结果 治疗组腹胀或腹痛症状改善率高于对照组,差异有统计学意义(P<0。05)。治疗组总有效率高于对照组,差异有统计学意义(P<0。05)。2组治疗后血清5-HT、IL-1β均下降,但治疗组较对照组下降更明显,差异有统计学意义(P<0。05)。治疗后,2组腹痛积分和腹泻积分下降,且治疗组较对照组下降更明显,差异有统计学意义(P<0。05)。2组治疗后汉密尔顿焦虑量表(HAMA)评分和肠易激综合征生活质量量表(IBS-QOL)评分均较治疗前下降,且治疗组HAMA评分和IBS-QOL评分低于对照组,差异有统计学意义(P<0。01)。结论 仙鹤草-白术可能通过降低5-HT、IL-1β的分泌水平,达到治疗腹泻型肠易激综合征脾虚湿阻证的作用。
Effect of Xianhecao-Baizhu in treatment of diarrhea irritable bowel syndrome with spleen deficiency and dampness type
Objective To explore the clinical effect and mechanism of Xianhecao-Baizhu in treat-ment of diarrhea irritable bowel syndrome with spleen deficiency and dampness type.Methods A total of 120 patients were randomly divided into treatment group and control group,with 60 cases in each group.The treatment group was given Xianhecao-Baizhu Decoction orally,and the control group was given pefican combined with montmorillonite powder orally.The course of treatment lasted for 1 month.The improvement of main symptoms,comprehensive efficacy,serum levels of 5-HT and IL-1 βbefore and after treatment in two groups were observed.Results The improvement rate of abdominal distension or abdominal pain in the treatment group was higher than that in the control group(P<0.05).The total effective rate of the treatment group was higher than that of the control group(P<0.05).After treatment,serum 5-hydroxytryptamine(5-HT)and interleukin-1 β(IL-1 β)levels were decreased in both groups,but the decrease was more obvious in the treatment group than in the con-trol group(P<0.05).After treatment,abdominal pain scores and diarrhea scores in the two groups decreased,and the decrease in the treatment group was more obvious than that in the control group(P<0.05).The scores of Hamilton Anxiety Scale(HAMA)and IBS Quality of Life Scale(IBS-QOL)in the two groups after treatment were decreased compared with those before treatment,and the HAMA and IBS-QOL scores in the treatment group were lower than those in the control group(P<0.01).Conclusion Xianhecao-Baizhu can treat diarrhea irritable bowel syndrome with spleen de-ficiency and dampness type by reducing the secretion levels of 5-HT and IL-1 β.

XianhecaoBaizhudiarrhea irritable bowel syndrome5-hydroxytryptamineinterleukin-1 βHamilton Anxiety ScaleQuality of Life Scale

张梓岗、翟金海、汤瑜

展开 >

江苏省江阴市中医院医疗集团顾山分院,江苏江阴,214414

江苏医药职业学院,江苏盐城,224005

江苏省江阴市中医院,江苏江阴,214413

仙鹤草 白术 腹泻型肠易激综合征 5-羟色胺 白细胞介素-1β 汉密尔顿焦虑量表 生活质量量表

江苏省名老中医药专家传承工作室建设项目江苏省名老中医药专家学术经验继承工作专项资金资助项目

201180号200969号

2024

实用临床医药杂志
扬州大学,中国高校科技期刊研究会

实用临床医药杂志

CSTPCD
影响因子:1.543
ISSN:1672-2353
年,卷(期):2024.28(14)
  • 13